Company analysis – Torrent Pharma Ltd.

Company reports prepared by SKBKS provide strategic analysis of the leading companies listed on BSE. Presented in simple format, these reports are crucial resource for our customers, quickly enhancing their understanding of the market and competitors.

Company reports include company shares by region and market sector, brand portfolio, marketing and distribution strategies, SWOT analysis of the company, evaluation of company growth over five years, performance of the scrip on the bourses, and much more. A detailed yet focused analysis of the company.

TORRENT PHARMACEUTICAL

 Key Highlights

Torrent Pharma Ltd (TPL), with annual revenues of more than Rs66bn is the flagship company of the Rs183bn Torrent Group. TPL continues to be at the forefront of the Indian pharmaceutical industry with many of its products ranking among the top 500 brands (AIOCD Dataset) in India. Its widespread international presence also includes several markets where Torrent is amongst the leading pharmaceutical companies in the respective countries. As of 31st Mar’16, the company has 16 subsidiaries, out of which 4 are step down subsidiaries.

TOC FOR THE COMPANY PROFILE

1.Corporate Overview

– Company History

– Business Structure/ Overview

– Management

– Milestones

– Major Merger & Acquisitions (five years)

2.Product and Services

– Product and Services Overview

– Product Mix

3.Key Business Strategies

– Marketing Strategy

– Financial strategy

– Effective Sales & Distribution Channels

– Market Positioning Strategy

– Value Pricing Strategy

4.Financial Highlights

– Five Year Financial Summary

– Financial Performance (Interpretation-Performance of the Company for the quarter ended and financial year ended)

— Revenue Changes (Revenue Growth/ decline-in Volume and Prices)

— Revenue Summary by Geographical distribution/ Segmental

— Analyzing Cost Changes (Cost Structure Analysis)

— COGS (Increase or Decrease)

— Selling General & Admin expenses

— Salary & Wages

— Interest Income/ Expenses

5.Ratios and Market Indicators

– Solvency, Operational Efficiency and Efficiency in use of Capital Assets

– Stock Analysis

— Relative Market Cap Performance

— Owner Structure (Share holding pattern)

6.SWOT Analysis

– Strength

– Weaknesses

– Opportunities

– Threats

7.Competitive Analysis

– Competitors (Peer Comparison-at least five companies)

— Key Financials (Sales, EBITDA, PAT)

— Cost Structure

8.Future Strategies

9.Future performance Analysis

– Forecast for two year

  1. Concluding Discussion (Outlook)

– The Industry (Market Size & Growth)

– Trends & Drivers

– Company outlook

– Analyst view

List of Figures

  1. Product Mix
  2. Company performance (5 years)
  3. Revenue by Geographical Distribution/Segmental
  4. Cost Structure (as percentage of sales)
  5. Raw Material Mix
  6. Stock Performance (Relative performance)
  7. Share Holding Pattern (latest quarter ended)
  8. Peer sales

List of Tables

  1. Management
  2. Major Mergers & Acquisitions
  3. Product and Services
  4. Financial Highlights (Five year)
  5. Key Financial Ratios
  6. Financial Performance for the quarter and year ended
  7. Cost Structure (as percentage of sales)
  8. Stock Statistics
  9. Peer Comparison (as percentage of net Sales)
  10. Earnings & Income Estimates (two year forecast)

 

 

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s